Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Am J Med Sci. 2011 May;341(5):388-93. doi: 10.1097/MAJ.0b013e31821483fa.

Dyslipidemia intervention in metabolic syndrome: emphasis on improving lipids and clinical event reduction.

Author information

  • 1Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School, the University of Queensland School of Medicine, New Orleans, Louisiana 70121, USA. clavie@ochsner.org


The metabolic syndrome is a common disorder characterized by central (especially intra-abdominal) obesity, hypertension, impaired glucose tolerance and atherogenic dyslipidemia (including the combination of hypertriglyceridemia and low levels of high-density lipoprotein cholesterol). In this article, the authors review interventions to improve this lipid profile and potentially reduce the risk of major cardiovascular events in patients with metabolic syndrome.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk